Page last updated: 2024-09-03

5-aza-2'-deoxycytidine-5'-triphosphate and Bladder Cancer

5-aza-2'-deoxycytidine-5'-triphosphate has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alp, E; Gurocak, S; Konac, E; Menevse, S; Onen, IH; Sozen, S; Varol, N; Yilmaz, A1

Other Studies

1 other study(ies) available for 5-aza-2'-deoxycytidine-5'-triphosphate and Bladder Cancer

ArticleYear
The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24).
    DNA and cell biology, 2014, Volume: 33, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Azacitidine; beta Catenin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D; Cytidine Triphosphate; Dose-Response Relationship, Drug; Epigenomics; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Hydroxamic Acids; Urinary Bladder Neoplasms; Wnt Proteins

2014